CAPRICOR THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
CAPRICOR THERAPEUTICS, INC. (CAPR) had Prepaid Expense and Other Assets, Current of $4.19 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $4.19M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $4.48M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $4.81M; Prepaid Expense and Other Assets, Current as first filed $4.75M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.33M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.19M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.48M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $4.81M 10-Q · filed 2026-08-14 | $4.75M 10-K · filed 2026-03-17 |
| 2025-09-30 | $2.33M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.27M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.41M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.50M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $385.06K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $837.22K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.13M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $995.78K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $458.42K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $583.84K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $875.09K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $919.89K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $343.68K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $659.27K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $943.25K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.16M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $278.91K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $653.34K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $736.36K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.01M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $174.19K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $249.88K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $433.98K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $571.38K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $129.16K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $375.42K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $425.94K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $724.18K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $426.42K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $388.12K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $522.35K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $501.16K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $190.28K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $239.33K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $398.18K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $342.89K 10-K · filed 2018-03-22 | |
| 2016-09-30 | $118.22K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $239.26K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $321.42K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $210.60K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $92.48K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $130.72K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $202.98K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $235.52K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $105.10K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $123.06K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $169.58K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $222.95K 10-K · filed 2015-03-16 | $222.76K 10-K · filed 2014-03-31 |
| 2013-09-30 | $37.98K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $60.09K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $112.74K 10-Q · filed 2013-06-21 | |
| 2012-12-31 | $38.04K 10-K · filed 2014-03-31 | $124.91K 10-K · filed 2013-06-21 |
| 2012-09-30 | $155.84K 10-Q · filed 2013-06-21 | |
| 2012-06-30 | $164.66K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $220.39K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $271.30K 10-Q · filed 2013-06-21 | |
| 2011-09-30 | $420.65K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $379.88K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $219.09K 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |